학술논문
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
Document Type
Article
Author
Source
In Blood Advances 9 April 2024 8(7):1612-1620
Subject
Language
ISSN
2473-9529